Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

BACKGROUND: Patients with metastatic breast cancer (MBC) represent a heterogeneous group, with large differences in outcomes from individual patients. VE-cadherin, an endothelial-specific cadherin, was shown to promote tumour proliferation and angiogenesis. Soluble VE-cadherin has been recently asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294483/
https://www.ncbi.nlm.nih.gov/pubmed/28056463
http://dx.doi.org/10.1038/bjc.2016.427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294483/
https://www.ncbi.nlm.nih.gov/pubmed/28056463
http://dx.doi.org/10.1038/bjc.2016.427

Ejemplares similares